129 related articles for article (PubMed ID: 109047)
1. The use of triazine inhibitors in mapping the active site region of Lactobacillus casei dihydrofolate reductase.
Dietrich SW; Smith RN; Brendler S; Hansch C
Arch Biochem Biophys; 1979 May; 194(2):612-9. PubMed ID: 109047
[No Abstract] [Full Text] [Related]
2. [Quantitative correlations of the inhibitory effects of triazines on the isolated dihydrofolate reductase from Lactobacillus casei cells and the cells in culture].
Guo ZR
Yao Xue Xue Bao; 1983 Jan; 18(1):33-8. PubMed ID: 6407279
[No Abstract] [Full Text] [Related]
3. Comparison of the inhibition of methotrexate-sensitive and -resistant Lactobacillus casei cell cultures with purified Lactobacillus casei dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-substituted-phenyl)-s-triazines. Use of quantitative structure-activity relationships in making inferences about the mechanism of resistance and the structure of the enzyme is situ compared with the enzyme in vitro.
Coats EA; Genther CS; Dietrich SW; Guo ZR; Hansch C
J Med Chem; 1981 Dec; 24(12):1422-9. PubMed ID: 6796688
[TBL] [Abstract][Full Text] [Related]
4. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s.
Hansch C; Hathaway BA; Guo ZR; Selassie CD; Dietrich SW; Blaney JM; Langridge R; Volz KW; Kaufman BT
J Med Chem; 1984 Feb; 27(2):129-43. PubMed ID: 6420569
[TBL] [Abstract][Full Text] [Related]
5. Voronoi modeling: the binding of triazines and pyrimidines to L. casei dihydrofolate reductase.
Bradley MP; Crippen GM
J Med Chem; 1993 Oct; 36(21):3171-7. PubMed ID: 8230104
[TBL] [Abstract][Full Text] [Related]
6. The charge state of substrates and inhibitors when bound to Lactobacillus casei dihydrofolate reductase [proceedings].
Hood K; Roberts GC
Biochem Soc Trans; 1977; 5(3):771-2. PubMed ID: 20381
[No Abstract] [Full Text] [Related]
7. 1H nuclear magnetic resonance studies of Lactobacillus casei dihydrofolate reductase: effects of substrate and inhibitor binding on the histidine residues.
Birdsall B; Griffiths DV; Roberts GC; Feeney J; Burgen A
Proc R Soc Lond B Biol Sci; 1977 Mar; 196(1124):251-65. PubMed ID: 16268
[No Abstract] [Full Text] [Related]
8. 1H nuclear magnetic resonance studies of the tyrosine residues of selectively deuterated Lactobacillus casei dihydrofolate reductase.
Feeney J; Roberts GC; Birdsall B; Griffiths DV; King RW; Scudder P; Burgen A
Proc R Soc Lond B Biol Sci; 1977 Mar; 196(1124):267-90. PubMed ID: 16269
[No Abstract] [Full Text] [Related]
9. Confirmation of collateal sensitivity to pyrimethamine in Lactobacillus casei ATCC 7469 resistant to chlorguanide triazine.
Smith CC; Genther CS
Ann N Y Acad Sci; 1971 Nov; 186():185-6. PubMed ID: 5002297
[No Abstract] [Full Text] [Related]
10. A 1H NMR study of the interactions and conformations of rationally designed brodimoprim analogues in complexes with Lactobacillus casei dihydrofolate reductase.
Birdsall B; Feeney J; Pascual C; Roberts GC; Kompis I; Then RL; Müller K; Kroehn A
J Med Chem; 1984 Dec; 27(12):1672-6. PubMed ID: 6438320
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
Hansch C; Li R; Blaney JM; Langridge R
J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the DNA binding region recognized by dihydrofolate reductase from lactobacillus casei.
Gronenborn AM; Clore GM
J Biol Chem; 1983 Sep; 258(18):11256-9. PubMed ID: 6309840
[TBL] [Abstract][Full Text] [Related]
13. TPNH-dependent binding of amethopterin by dihydrofolate reductase from Lactobacillus casei.
Otting F; Huennekens FM
Arch Biochem Biophys; 1972 Sep; 152(1):429-31. PubMed ID: 4403695
[No Abstract] [Full Text] [Related]
14. Reduction of oxidised folates by dihydrofolate reductase from methotrexate-resistant Lactobacillus casei.
McIntyre LJ; Harding NG
Biochim Biophys Acta; 1977 Jun; 482(2):261-71. PubMed ID: 18181
[TBL] [Abstract][Full Text] [Related]
15. A 1H n.m.r. study of the role of the glutamate moiety in the binding of methotrexate to Lactobacillus casei dihydrofolate reductase.
Antonjuk DJ; Birdsall B; Cheung HT; Clore GM; Feeney J; Gronenborn A; Roberts GC; Tran TQ
Br J Pharmacol; 1984 Feb; 81(2):309-15. PubMed ID: 6423020
[TBL] [Abstract][Full Text] [Related]
16. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
Selassie CD; Fang ZX; Li RL; Hansch C; Debnath G; Klein TE; Langridge R; Kaufman BT
J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of dihydrofolate reductase from Lactobacillus casei by diethyl pyrocarbonate.
Daron HH; Aull JL
Biochemistry; 1982 Feb; 21(4):737-41. PubMed ID: 6803828
[TBL] [Abstract][Full Text] [Related]
18. Carbodiimide-dependent inactivation of dihydrofolate reductase.
Reinsch JW; Dunlap RB
Biochem Biophys Res Commun; 1980 Jul; 95(2):785-91. PubMed ID: 6774715
[No Abstract] [Full Text] [Related]
19. Direct experimental evidence for competitive inhibition of dihydrofolate reductase by methotrexate.
Waltham MC; Holland JW; Robinson SC; Winzor DJ; Nixon PF
Biochem Pharmacol; 1988 Feb; 37(3):535-9. PubMed ID: 3122764
[TBL] [Abstract][Full Text] [Related]
20. Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
Ghose AK; Crippen GM
J Med Chem; 1983 Jul; 26(7):996-1010. PubMed ID: 6864738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
